149707-76-6

Basic information

• Product Name: O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate
• Synonyms: O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate
• CAS NO: 149707-76-6
• Molecular Weight: 740.978
• Mol File: 149707-76-6.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate(CAS DataBase Reference)
• NIST Chemistry Reference: O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate(149707-76-6)
• EPA Substance Registry System: O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) trichloroacetimidate(149707-76-6)

Safety Data

• Hazardous Substances Data: 149707-76-6(Hazardous Substances Data)

Upstream product

• 2592-58-7 1,2,3,4,6-Penta-O-benzoyl-α-D-galactopyranose 
• 61198-88-7 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide 
• 545-06-2 trichloroacetonitrile 
• 113544-55-1 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranose 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-D-glucopyranoside 
• 14218-11-2 2,3,4,6-tetra-O-benzoylglucosyl bromide 
• 165877-99-6 2,3,4,6-tetra-O-Bz-β-D-glucopyranosyl bromide 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-β-D-glucopyranose 
• 64768-20-3 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranose 
• 492-61-5 β-D-glucose 
• 98-88-4 benzoyl chloride 
• 2280-44-6 D-Glucose 
• 627466-64-2 2,3,4,6-tetra-O-benzoyl-D-glucopyranose 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-β-D-galactopyranose 

Downstream Products

• 192126-03-7 C₄₉H₅₈O₁₄SSi 
• 206257-81-0 (R)-1-dimethylthexylsilyloxy-3-butene-2-yl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside 
• 478550-10-6 2-azido-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2-deoxy-1-O-hexyl-sn-glycerol 
• 478550-11-7 2-azido-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2-deoxy-1-O-dodecyl-sn-glycerol 
• 478550-12-8 2-azido-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2-deoxy-1-O-hexadecyl-sn-glycerol 
• 634603-13-7 4-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-2-O-acetyl-3,4-di-O-benzoyl-β-D-galactopyranoside 
• 753500-17-3 4-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-3-O-allyl-2,4-di-O-benzoyl-β-D-galactopyranoside 
• 212128-08-0 phenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-2,3,4-tri-O-benzoyl-1-thio-β-D-galactopyranoside 
• 821018-29-5 phenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-2,4-di-O-benzoyl-3-O-chloroacetyl-β-D-galactopyranosyl-(1->6)-2,3,4-tri-O-benzoyl-1-thio-β-D-galactopyranoside 
• 865294-29-7 4-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->3)-6-O-acetyl-2,4-di-O-benzoyl-β-D-galactopyranoside 
• 942270-79-3 3',5'-bis(O-tert-butyldimethylsilyl)-2'-deoxy-5-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)oxymethyluridine 
• 1008131-08-5 benzyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->4)-2,3-isopropylidene-α-L-rhamnopyranoside 
• 1008131-10-9 1-O-D-hydrocholesterolyl-2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside 
• 70751-54-1 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-1,2,5,6-bis(di-O-isopropylidene)-α-D-galactopyranoside 

Relevant articles and documents

VACCINE COMPOSITIONS AND ANTIBODIES FOR LYME DISEASE

The present invention relates to vaccine compositions comprising lipid antigens, antibodies targeting lipid antigens, pharmaceutical compositions comprising such and their use in diagnosing, monitoring, treating, and preventing infectious disease, such as Lyme disease. In one aspect, administered is a therapeutically effective amount of a vaccine composition comprising a lipid antigen, an antibody or fragment thereof binding a lipid antigen, and/or a pharmaceutical composition comprising an antibody or fragment thereof binding a lipid antigen. Other aspects are described.

ENDOSOMAL CLEAVABLE LINKERS

The present disclosure relates generally to cleavable linkers and uses thereof.

3 - monosaccharide acid oxygen glucoside oleanolic alkane type and wusu alkane triterpene saponin derivative and its preparation method and application

The invention discloses a 3-monouronic acid o-glycoside oleanane type and ursane type triterpenoid saponin derivative. The derivative has a structural formula as shown in the specification, wherein R4 is one of H atom, alkyl containing 1-10 carbons, alkyl